22:19:20 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-03-26 Bokslutskommuniké 2023
2023-12-22 Extra Bolagsstämma 2023
2023-11-23 Kvartalsrapport 2023-Q3
2023-08-11 Kvartalsrapport 2023-Q2
2023-05-17 X-dag ordinarie utdelning COALA 0.00 SEK
2023-05-16 Årsstämma 2023
2023-05-04 Kvartalsrapport 2023-Q1
2023-03-31 Bokslutskommuniké 2022
2023-01-26 Extra Bolagsstämma 2022
2022-11-16 Kvartalsrapport 2022-Q3
2022-08-17 Kvartalsrapport 2022-Q2
2022-05-31 X-dag ordinarie utdelning COALA 0.00 SEK
2022-05-30 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-05-04 Kvartalsrapport 2022-Q1
2022-02-23 Bokslutskommuniké 2021
2021-12-14 X-dag ordinarie utdelning COALA 0.00 SEK
2021-11-04 Split COALA 50:1
2021-10-29 Extra Bolagsstämma 2021
2021-08-10 Extra Bolagsstämma 2021
2021-06-24 Kvartalsrapport 2021-Q3
2021-03-25 Kvartalsrapport 2021-Q2
2020-12-23 X-dag ordinarie utdelning COALA 0.00 SEK
2020-12-22 Kvartalsrapport 2021-Q1
2020-12-22 Årsstämma 2021
2020-10-22 Bokslutskommuniké 2020
2020-06-25 Kvartalsrapport 2020-Q3
2020-03-26 Kvartalsrapport 2020-Q2
2019-12-20 X-dag ordinarie utdelning COALA 0.00 SEK
2019-12-19 Årsstämma 2020
2019-12-12 Kvartalsrapport 2020-Q1
2019-10-30 Extra Bolagsstämma 2019
2019-10-10 Bokslutskommuniké 2019
2019-06-26 Kvartalsrapport 2019-Q3
2019-03-26 Kvartalsrapport 2019-Q2
2018-12-21 X-dag ordinarie utdelning COALA 0.00 SEK
2018-12-20 Kvartalsrapport 2019-Q1
2018-12-20 Årsstämma 2019
2018-10-11 Bokslutskommuniké 2018
2018-03-27 Kvartalsrapport 2018-Q2
2017-12-22 X-dag ordinarie utdelning COALA 0.30 SEK
2017-12-21 Årsstämma 2018
2017-10-12 Bokslutskommuniké 2017
2017-07-21 Kvartalsrapport 2018-Q1
2017-06-21 Kvartalsrapport 2017-Q3
2017-03-27 Kvartalsrapport 2017-Q2
2016-12-22 X-dag ordinarie utdelning COALA 0.25 SEK
2016-12-21 Årsstämma 2017
2016-12-21 Kvartalsrapport 2017-Q1
2016-10-19 Bokslutskommuniké 2016
2016-06-23 Kvartalsrapport 2016-Q3
2016-03-24 Kvartalsrapport 2016-Q2
2015-12-18 X-dag ordinarie utdelning COALA 0.25 SEK
2015-12-17 Årsstämma 2016
2015-12-17 Kvartalsrapport 2016-Q1
2015-10-22 Bokslutskommuniké 2015
2015-06-23 Kvartalsrapport 2015-Q3
2015-03-26 Kvartalsrapport 2015-Q2
2014-12-19 X-dag ordinarie utdelning COALA 0.00 SEK
2014-12-18 Årsstämma 2015
2014-12-18 Kvartalsrapport 2015-Q1
2014-10-23 Bokslutskommuniké 2014
2014-06-26 Kvartalsrapport 2014-Q3
2014-04-02 Kvartalsrapport 2014-Q2
2014-01-17 X-dag ordinarie utdelning COALA 0.00 SEK
2014-01-16 Årsstämma 2014
2014-01-15 Kvartalsrapport 2014-Q1
2013-10-31 Analytiker möte 2013
2013-10-31 Bokslutskommuniké 2013
2013-06-27 Kvartalsrapport 2013-Q3
2013-06-05 Split COALA 200:1
2013-03-27 Extra Bolagsstämma 2013
2013-03-25 Kvartalsrapport 2013-Q2
2013-01-18 X-dag ordinarie utdelning COALA 0.00 SEK
2013-01-17 Årsstämma 2013
2013-01-16 Kvartalsrapport 2013-Q1
2012-10-24 Bokslutskommuniké 2012
2012-06-27 Kvartalsrapport 2012-Q3
2012-03-30 Kvartalsrapport 2012-Q2
2012-01-20 X-dag ordinarie utdelning COALA 0.00 SEK
2012-01-19 Årsstämma 2012
2012-01-18 Kvartalsrapport 2012-Q1
2011-10-27 Bokslutskommuniké 2011
2011-06-30 Kvartalsrapport 2011-Q3
2011-04-06 Kvartalsrapport 2011-Q2
2011-01-21 X-dag ordinarie utdelning COALA 0.00 SEK
2011-01-20 Årsstämma 2011
2011-01-19 Kvartalsrapport 2011-Q1
2010-10-22 Kvartalsrapport 2010-Q3
2010-10-21 Bokslutskommuniké 2010
2010-06-23 Kvartalsrapport 2010-Q2
2010-03-26 Kvartalsrapport 2010-Q1
2010-01-13 Kvartalsrapport 2009-Q1
2009-10-22 Kvartalsrapport 2009-Q3
2009-06-17 Kvartalsrapport 2009-Q2
2009-01-28 Årsstämma 1
2006-03-01 Split COALA 1:2
2005-05-04 Split COALA 1:2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Coala Life är verksamt inom medicinteknik inriktade mot smartphone- och molnbaserad hjärt- och lungdiagnostik. Bolaget har utvecklat och lanserat Coala Heart Monitor, en produktplattform som möjliggör långtidsmonitorering, analys och algoritmbaserad diagnostik av hjärta och lungor på distans. Bolaget är verksamt inom Europa och USA med huvudkontor i Uppsala.
2023-11-23 07:00:00

Third quarter 2023

  • Net sales increased to SEK 14.1 M (5.0).
  • EBITDA amounted to SEK -30.0 M (-27.8).
  • Operating income totaled SEK -32.3 M (-28.2).
  • Profit after tax was SEK -31.4 M (-18.5).
  • Earnings per share was SEK -0.1 (-0.3).
  • Cash flow from operating activities was SEK -6.4 M (-36.1).

The period, January 1, 2023 – September 30, 2023

  • Net sales increased to SEK 39.8 M (7.5).
  • EBITDA amounted to SEK -90.5 M (-99.4).
  • Operating income totaled SEK -97.1 M (-101.7).
  • Profit after tax was SEK -94.3 M (-88.6).
  • Earnings per share was SEK -0.4 (-1.4).
  • Cash flow from operating activities was SEK -65.1 M (-122.5).

Events in the quarter

  • On September 25, the outcome was announced of the warrants that were issued in the first quarter of 2023, and the company received approximately SEK 5.5 M less issue costs.
  • On September 19, the company took out a bridge loan of SEK 5 M to secure short-term liquidity needs.
  • On September 11, the company initiated a cost-saving program to reduce total costs by 30% that it is deemed will be fully implemented in January 2024.
  • On September 1, CFO Richard Roa left the company and the company’s controller Robin Danielsson Källmark was appointed interim CFO.
  • On August 2, the company announced that Emma Strömfeldt had resigned as a Board member of Coala Life Group AB (publ).
  • On July 11, the company issued a notice to attend an Extraordinary General Meeting on July 31 for a resolution on a directed new share issue for some of the company’s largest owners. The directed new share issue was approved at the Extraordinary General Meeting, which will raise SEK 17 M for the company, less transaction costs.

Events after the end of the quarter

  • On November 21, the company announced that the Board of Directors is proposed to resolve during an Extraordinary General Meeting on December 22, 2023 on an upcoming rights issue of approximately SEK 75.4 M and on warrants of approximately SEK 18,8 M. The rights issue is planned to run from January 8, 2024 to January 22, 2024 and the subscription period for the warrants is planned to run between May 30, 2024 to June 12, 2024.
  • On November 21, the company entered into new brigde loan agreements of SEK 20 M together with existing loans of SEK 5 M.

Extract from comments from the CEO, Dan Pitulia
Coala Life’s focus is the US market for remote patient monitoring (RPM) in the home environment, where we offer Managed RPM, a full-service solution. Our service provides patients and the health care sector with solutions for non-invasive and patient-centered indicative decision support, using algorithms to predict heart and lung disease and thereby contribute to avoiding certain conditions developing. Our strategic goal is to dramatically improve quality of life and clinical outcomes for the millions of patients affected by chronic or acute cardiovascular and other diseases.

We operate in a market undergoing rapid growth. According to Medi-Tech Insight, the global healthcare consultancy, the total RPM market in the US will reach over USD 18 billion by 2026, with an annual rate of growth of 25%. Coala Life is well positioned to take part in this growth, and we have high expectations for our future progress.

Our sales growth has been good, in particular since our operations in the US started up in earnest in the spring of 2022. Sales in the third quarter was SEK 14.1 M, compared with SEK 5.0 M in the year-earlier period. Sales from January to September totaled SEK 39.8 M (SEK 7.5 M in the year-earlier period). The gross margin remained high, totaling 85% (83) for the period.

Our expanded venture in the US market has required a professional organization that is capable both as regards attracting new clinics as part of sales initiatives and delivering on the follow-up, reporting and assistance that patient monitoring requires. This has involved a substantial increase in the organization, and the average number of full-time employees and consultants in the period was 89 (39) and has lead us to not yet achieve improvements in operating income, which for the third quarter totaled SEK -32.3 M (-28.2). The company therefore initiated a cost-saving program in September to lower its total costs by 30%. The effect of the measures we have taken to date will be a gradual reduction of costs, and the program is expected to be fully implemented in January of 2024. Further efficiency improvements have now been identified, with savings of just over SEK 5 M on an annual basis, and these will also yield a full effect in Q1 2024.

Comments from our CEO can be read in full in the interim report.

The interim report is available on the company´s website:
https://investors.coalalife.com/en/investor-relations/financial-reports-and-presentations/